SEARCH

SEARCH BY CITATION

References

  • Abraham SM, Lawrence T, Kleiman A, Warden P, Medghalchi M, Tuckermann J et al. (2006). Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med 203: 18831889.
  • Adcock IM, Barnes PJ (2008). Molecular mechanisms of corticosteroid resistance. Chest 134: 394401.
  • Ayroldi E, Riccardi C (2009). Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J 23: 36493658.
  • Ayroldi E, Zollo O, Bastianelli A, Marchetti C, Agostini M, Di Virgilio R et al. (2007). GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling. J Clin Invest 117: 16051615.
  • Barnes PJ (2006). How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol 148: 245254.
  • Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, Fitzgerald M et al. (2008). Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31: 143178.
  • Bhavsar P, Hew M, Khorasani N, Torrego A, Barnes PJ, Adcock I et al. (2008). Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax 63: 784790.
  • Borgstrom L, Asking L, Thorsson L (2005). Idealhalers or realhalers? A comparison of Diskus and Turbuhaler. Int J Clin Pract 59: 14881495.
  • van den Bosch JM, Westermann CJ, Aumann J, Edsbacker S, Tonnesson M, Selroos O (1993). Relationship between lung tissue and blood plasma concentrations of inhaled budesonide. Biopharm Drug Dispos 14: 455459.
  • van den Brink KI, Boorsma M, Staal-van den Brekel AJ, Edsbacker S, Wouters EF, Thorsson L (2008). Evidence of the in vivo esterification of budesonide in human airways. Br J Clin Pharmacol 66: 2735.
  • Busse WW, Pedersen S, Pauwels RA, Tan WC, Chen YZ, Lamm CJ et al. (2008). The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 121: 11671174.
  • Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I et al. (2007). Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol 120: 13601367.
  • Chen W, Rogatsky I, Garabedian MJ (2006). MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor. Mol Endocrinol 20: 560572.
  • Chivers JE, Gong W, King EM, Seybold J, Mak JC, Donnelly LE et al. (2006). Analysis of the dissociated steroid, RU24858, does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids. Mol Pharmacol 70: 20842095.
  • Clark AR (2007). Anti-inflammatory functions of glucocorticoid-induced genes. Mol Cell Endocrinol 275: 7997.
  • Clark AR, Martins JR, Tchen CR (2008). Role of dual specificity phosphatases in biological responses to glucocorticoids. J Biol Chem 283: 2576525769.
  • Davies TH, Ning YM, Sanchez ER (2002). A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem 277: 45974600.
  • Di Marco B, Massetti M, Bruscoli S, Macchiarulo A, Di Virgilio R, Velardi E et al. (2007). Glucocorticoid-induced leucine zipper (GILZ)/NF-kappaB interaction: role of GILZ homo-dimerization and C-terminal domain. Nucleic Acids Res 35: 517528.
  • Eddleston J, Herschbach J, Wagelie-Steffen AL, Christiansen SC, Zuraw BL (2007). The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J Allergy Clin Immunol 119: 115122.
  • Furst R, Schroeder T, Eilken HM, Bubik MF, Kiemer AK, Zahler S et al. (2007). MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium. FASEB J 21: 7480.
  • Jonat C, Rahmsdorf HJ, Park KK, Cato AC, Gebel S, Ponta H et al. (1990). Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62: 11891204.
  • Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, Cato AC (2001). Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 20: 71087116.
  • Kaur M, Chivers JE, Giembycz MA, Newton R (2008a). Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. Mol Pharmacol 73: 203214.
  • Kaur M, Holden NS, Wilson SM, Sukkar MB, Chung KF, Barnes PJ et al. (2008b). Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. Am J Physiol Lung Cell Mol Physiol 295: L505L514.
  • Kelly MM, Leigh R, Gilpin SE, Cheng E, Martin GE, Radford K et al. (2006a). Cell-specific gene expression in patients with usual interstitial pneumonia. Am J Respir Crit Care Med 174: 557565.
  • Kelly MM, Leigh R, Jayaram L, Goldsmith CH, Parameswaran K, Hargreave FE (2006b). Eosinophilic bronchitis in asthma: a model for establishing dose-response and relative potency of inhaled corticosteroids. J Allergy Clin Immunol 117: 989994.
  • Kelly MM, O'Connor TM, Leigh R, Otis J, Gwozd C, Gauvreau GM et al. (2010). Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. J Allergy Clin Immunol 125: 349356.
  • King EM, Holden NS, Gong W, Rider CF, Newton R (2009). Inhibition of NF-kappaB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK. J Biol Chem 284: 2680326815.
  • Lasa M, Brook M, Saklatvala J, Clark AR (2001). Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol Cell Biol 21: 771780.
  • Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR (2002). Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 22: 78027811.
  • Maier JV, Brema S, Tuckermann J, Herzer U, Klein M, Stassen M et al. (2007). Dual specificity phosphatase 1 knockout mice show enhanced susceptibility to anaphylaxis but are sensitive to glucocorticoids. Mol Endocrinol 21: 26632671.
  • Miller-Larsson A, Selroos O (2002). No evidence of glucocorticosteroid-induced apoptosis of airway epithelial cells in vivo. Am J Respir Crit Care Med 165: 15671568.
  • Mittelstadt PR, Ashwell JD (2001). Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J Biol Chem 276: 2960329610.
  • Newton R, Holden NS (2007). Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor? Mol Pharmacol 72: 799809.
  • Newton R, Seybold J, Kuitert LM, Bergmann M, Barnes PJ (1998). Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J Biol Chem 273: 3231232321.
  • Newton R, King EM, Gong W, Rider CF, Staples KJ, Holden NS et al. (2010a). Glucocorticoids inhibit IL-1beta-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1. Biochem J 427: 113124.
  • Newton R, Leigh R, Giembycz MA (2010b). Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases. Pharmacol Ther 125: 286327.
  • Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV et al. (2003). Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 361: 10711076.
  • Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST (2007). Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol 119: 14541461.
  • Proud D, Sanders SP, Wiehler S (2004). Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo. J Immunol 172: 46374645.
  • Rider CF, King EM, Holden NS, Giembycz MA, Newton R (2011). Inflammatory stimuli inhibit glucocorticoid-dependent transactivation in human pulmonary epithelial cells: rescue by long-acting 2-adrenoceptor agonists. J Pharmacol Exp Ther 338: 860869.
  • Ristimaki A, Narko K, Hla T (1996). Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J 318: 325331.
  • Schacke H, Docke WD, Asadullah K (2002). Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96: 2343.
  • Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr (1995). Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270: 283286.
  • So AY, Cooper SB, Feldman BJ, Manuchehri M, Yamamoto KR (2008). Conservation analysis predicts in vivo occupancy of glucocorticoid receptor-binding sequences at glucocorticoid-induced genes. Proc Natl Acad Sci U S A 105: 57455749.
  • Stechschulte LA, Sanchez ER (2011). FKBP51-a selective modulator of glucocorticoid and androgen sensitivity. Curr Opin Pharmacol 11: 332337.
  • Stellato C (2004). Post-transcriptional and nongenomic effects of glucocorticoids. Proc Am Thorac Soc 1: 255263.
  • Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B (2000). Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 343: 332336.
  • Tchen CR, Martins JR, Paktiawal N, Perelli R, Saklatvala J, Clark AR (2010). Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes: unusual cis-acting elements and unexpected evolutionary divergence. J Biol Chem 285: 26422652.
  • Thorsson L, Edsbacker S, Conradson TB (1994). Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI. Eur Respir J 7: 18391844.
  • Tliba O, Damera G, Banerjee A, Gu S, Baidouri H, Keslacy S et al. (2008). Cytokines induce an early steroid resistance in airway smooth muscle cells: novel role of interferon regulatory factor-1. Am J Respir Cell Mol Biol 38: 463472.
  • Todorova L, Gurcan E, Miller-Larsson A, Westergren-Thorsson G (2006). Lung fibroblast proteoglycan production induced by serum is inhibited by budesonide and formoterol. Am J Respir Cell Mol Biol 34: 92100.
  • Walker RA (2006). Quantification of immunohistochemistry – issues concerning methods, utility and semiquantitative assessment I. Histopathology 49: 406410.
  • Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq C, Yamamoto KR (2004). Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc Natl Acad Sci U S A 101: 1560315608.